5_Cholinesterase Inhibitors - Maggini et al.

5_Cholinesterase Inhibitors - Maggini et al. - number...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
PLoS Medicine | www.plosmedicine.org 0460 27. Gauthier S, Touchon J (2005) Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 62: 1164–1166. 28. Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, et al. (2004) Ef± cacy of donepezil in mild cognitive impairment. A randomized placebo-controlled trial. Neurology 63: 651– 657. 29. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, et al. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352: 2379– 2388. 30. Jelic V, Kivipelto M, Winblad B (2005) Clinical trials in mild cognitive impairment: Lessons for the future. J Neurol Neurosurg Psychiatry. Epub ahead of print 23 November 2005. 31. Clinical Study Results Database. Protocol number GAL-INT-11. Available: http:⁄⁄www. clinicalstudyresults.org/documents/ company-study_96_1.pdf. Accessed 28 February 2006. 32. Clinical Study Results Database. Protocol
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: number GAL-INT-18. Available: http:⁄⁄www. clinicalstudyresults.org/documents/ company-study_96_2.pdf Accessed 28 February 2006. 33. US Food and Drug Administration [FDA] (2005) Alert for healthcare professionals on galantamine hydrochloride (marketed as Reminyl). Rockville (Maryland): FDA. Available: http:⁄⁄www.fda.gov/cder/drug/ InfoSheets/HCP/galantamineHCP.htm. Accessed 16 February 2006. 34. Takeda A, Loveman E, Clegg A, Kirby J, Picot J, et al. (2006) A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer’s disease. Int J Geriatr Psychiatry 21: 17–28. 35. Raschetti R, Maggini M, Sorrentino GC, Martini N, Caffari B, et al. (2005) A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer’s disease. Eur J Clin Pharmacol 61: 361–368. April 2006 | Volume 3 | Issue 4 | e140...
View Full Document

{[ snackBarMessage ]}

Ask a homework question - tutors are online